Ophelia

Ophelia identified a stark gap: over 3 million Americans struggled with opioid addiction, yet 80% avoided treatment entirely. ​​‌‌‌‌‌‌‌​‌‌​​‌​​​​​​‌‌​‌‌‌​​​‌‌The problem hit hardest among working professionals and parents who couldn't afford weeks away from jobs or feared losing custody of children. The barrier was measurable—treatment centers required in-person rehab stays, creating impossible choices between recovery and livelihood. Existing alternatives were limited: traditional 28-day inpatient programs, outpatient clinics requiring daily visits, or medication-only services without medical supervision. What validated Ophelia's approach early was the clinical evidence itself: medication-assisted treatment protocols were 6 times more effective than standard rehab, yet two-thirds of rehab facilities lacked on-site doctors to prescribe them. By combining telemedicine visits with home-delivered medication and ongoing support, Ophelia removed the access friction. Initial traction came from desperate patients who had previously rejected treatment—they finally had an option matching their real constraints.